The recent decision by the International Olympic Committee (IOC) to require genetic screening for athletes entered in female events has reignited a fierce debate about inclusion, science and privacy. Public criticism from prominent figures in sport — including two-time World Cup winner Megan Rapinoe and five-time Olympic gold medalist Sue Bird — has amplified concerns that the policy will do more harm than good for women in sport.
Rapinoe and Bird spoke about the change on their April 3 podcast episode, recorded on Trans Day of Visibility, calling the rules invasive and discriminatory. At the heart of the controversy is a return to screening for the SRY gene and other markers, a move that opponents say revives discredited practices and risks exposing private medical information for athletes who may not even know they have a variation in sex characteristics.
What the new IOC rules require
Under the policy announced by the IOC, athletes entered as women must undergo genetic testing that includes screening for the SRY gene. The SRY gene is typically associated with initiating male sex development, but experts stress that biological sex arises from a complex interaction of chromosomes, gonads, hormones and physical traits. The policy states athletes who test negative for the SRY gene are eligible to compete in the female category, while those who test positive are generally excluded with limited exceptions for certain intersex conditions.
One such exception applies to people with Complete Androgen Insensitivity Syndrome (CAIS), an intersex variation in which individuals with XY chromosomes develop typically female bodies and do not respond to testosterone in the usual way. The IOC’s approach reverses earlier guidance from 2015 that removed surgical requirements and avoided blanket genetic screening; critics argue the reversal reintroduces an inaccurate, blunt instrument to adjudicate eligibility.
Reactions from athletes and advocates
Voices across the sporting world have been vocal. Rapinoe described the move as hateful and a form of gatekeeping that attempts to narrow the definition of who can be a woman athlete. Bird characterized the debate as political fearmongering designed to score votes rather than protect athletes. Trans and intersex competitors — including champions like Caster Semenya and activists such as Chris Mosier — have also condemned the policy, arguing it stigmatizes marginalized athletes and ignores scientific nuance.
Scientific critiques and historical context
Many scientists and sports researchers have challenged the evidence cited by the IOC. Studies that examine performance differences after prolonged hormone therapy generally indicate that trans women’s metrics become closer to those of cisgender women over time, and genetic markers like the SRY gene do not by themselves determine athletic ability. Sex testing was phased out of the Olympics decades ago amid concerns about accuracy and ethics; critics point out the policy risks resurrecting those same problems and undermining trust in elite sport governance.
Broader consequences: privacy, equity and politics
Beyond eligibility questions, the policy raises serious privacy concerns. Genetic screening can reveal previously unknown intersex variations, meaning athletes could be simultaneously excluded from competition and publicly outed to teammates, media and governing bodies. Legal advocates warn that forced disclosure could be dangerous in countries where being transgender or intersex carries real risks. Organizations working with young athletes have already reported increased harassment and doxxing tied to the broader climate of suspicion.
Who else is affected?
Though relatively few transgender women have competed at the Olympic level, experts caution the rule’s reach will be broader. Intersex women and even some cisgender athletes could be impacted by routine genetic checks. Critics note that the policy’s stated aim of preserving fairness and safety is undermined if the scientific basis is weak, and they warn of disproportionate effects on athletes from the global South and other marginalized groups.
Political forces are part of the picture as well. The IOC says the measure is about sport integrity, but observers point to pressure from national governments and recent policies in some countries as shaping the decision. Whatever the motive, athletes and rights groups are mobilizing legal, medical and public campaigns to challenge the approach. The debate exposes deep tensions between attempts to standardize elite competition and the need to protect human dignity, privacy and equal access for all athletes.
As the conversation continues, the central questions remain: how to balance fairness with inclusion, whether the science supports such sweeping measures, and how to ensure that rule changes do not strip vulnerable athletes of dignity or the right to compete. For many advocates and competitors, the answer lies in evidence-based policy-making that centers athletes’ rights rather than political expediency.